BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 17981720)

  • 1. Adenosine A1-A2A receptor heteromers: new targets for caffeine in the brain.
    Ferre S; Ciruela F; Borycz J; Solinas M; Quarta D; Antoniou K; Quiroz C; Justinova Z; Lluis C; Franco R; Goldberg SR
    Front Biosci; 2008 Jan; 13():2391-9. PubMed ID: 17981720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opposite modulatory roles for adenosine A1 and A2A receptors on glutamate and dopamine release in the shell of the nucleus accumbens. Effects of chronic caffeine exposure.
    Quarta D; Ferré S; Solinas M; You ZB; Hockemeyer J; Popoli P; Goldberg SR
    J Neurochem; 2004 Mar; 88(5):1151-8. PubMed ID: 15009670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers.
    Ciruela F; Casadó V; Rodrigues RJ; Luján R; Burgueño J; Canals M; Borycz J; Rebola N; Goldberg SR; Mallol J; Cortés A; Canela EI; López-Giménez JF; Milligan G; Lluis C; Cunha RA; Ferré S; Franco R
    J Neurosci; 2006 Feb; 26(7):2080-7. PubMed ID: 16481441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the central ascending neurotransmitter systems in the psychostimulant effects of caffeine.
    Ferré S
    J Alzheimers Dis; 2010; 20 Suppl 1(Suppl 1):S35-49. PubMed ID: 20182056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A2A adenosine receptor antagonism enhances synaptic and motor effects of cocaine via CB1 cannabinoid receptor activation.
    Tozzi A; de Iure A; Marsili V; Romano R; Tantucci M; Di Filippo M; Costa C; Napolitano F; Mercuri NB; Borsini F; Giampà C; Fusco FR; Picconi B; Usiello A; Calabresi P
    PLoS One; 2012; 7(6):e38312. PubMed ID: 22715379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A detailed behavioral analysis of the acute motor effects of caffeine in the rat: involvement of adenosine A1 and A2A receptors.
    Antoniou K; Papadopoulou-Daifoti Z; Hyphantis T; Papathanasiou G; Bekris E; Marselos M; Panlilio L; Müller CE; Goldberg SR; Ferré S
    Psychopharmacology (Berl); 2005 Dec; 183(2):154-62. PubMed ID: 16205915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structures of Human A
    Cheng RKY; Segala E; Robertson N; Deflorian F; Doré AS; Errey JC; Fiez-Vandal C; Marshall FH; Cooke RM
    Structure; 2017 Aug; 25(8):1275-1285.e4. PubMed ID: 28712806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration.
    Karcz-Kubicha M; Antoniou K; Terasmaa A; Quarta D; Solinas M; Justinova Z; Pezzola A; Reggio R; Müller CE; Fuxe K; Goldberg SR; Popoli P; Ferré S
    Neuropsychopharmacology; 2003 Jul; 28(7):1281-91. PubMed ID: 12700682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of adenosine A1 and A2A receptors in the adenosinergic modulation of the discriminative-stimulus effects of cocaine and methamphetamine in rats.
    Justinova Z; Ferre S; Segal PN; Antoniou K; Solinas M; Pappas LA; Highkin JL; Hockemeyer J; Munzar P; Goldberg SR
    J Pharmacol Exp Ther; 2003 Dec; 307(3):977-86. PubMed ID: 14557381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of postural adjustment steps in hemiparkinsonian rats chronically treated with caffeine is mediated by concurrent blockade of A1 and A2A adenosine receptors.
    Bata-García JL; Tun-Cobá L; Alvarez-Cervera FJ; Villanueva-Toledo JR; Heredia-López FJ; Góngora-Alfaro JL
    Neuroscience; 2010 Mar; 166(2):590-603. PubMed ID: 20056138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential glutamate-dependent and glutamate-independent adenosine A1 receptor-mediated modulation of dopamine release in different striatal compartments.
    Borycz J; Pereira MF; Melani A; Rodrigues RJ; Köfalvi A; Panlilio L; Pedata F; Goldberg SR; Cunha RA; Ferré S
    J Neurochem; 2007 Apr; 101(2):355-63. PubMed ID: 17254024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the effects of caffeine and carbamazepine on striatal dopamine release by in vivo microdialysis.
    Okada M; Kiryu K; Kawata Y; Mizuno K; Wada K; Tasaki H; Kaneko S
    Eur J Pharmacol; 1997 Feb; 321(2):181-8. PubMed ID: 9063686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caffeine exposure alters adenosine system and neurochemical markers during retinal development.
    Brito R; Pereira-Figueiredo D; Socodato R; Paes-de-Carvalho R; Calaza KC
    J Neurochem; 2016 Aug; 138(4):557-70. PubMed ID: 27221759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of quasi-morphine withdrawal syndrome in adenosine A2A receptor knockout mice.
    Bilbao A; Cippitelli A; Martín AB; Granado N; Ortiz O; Bezard E; Chen JF; Navarro M; Rodríguez de Fonseca F; Moratalla R
    Psychopharmacology (Berl); 2006 Apr; 185(2):160-8. PubMed ID: 16470403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DARPP chocolate: a caffeinated morsel of striatal signaling.
    Bastia E; Schwarzschild MA
    Sci STKE; 2003 Jan; 2003(165):PE2. PubMed ID: 12527819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caffeine and the dopaminergic system.
    Cauli O; Morelli M
    Behav Pharmacol; 2005 Mar; 16(2):63-77. PubMed ID: 15767841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JNJ-40255293, a novel adenosine A2A/A1 antagonist with efficacy in preclinical models of Parkinson's disease.
    Atack JR; Shook BC; Rassnick S; Jackson PF; Rhodes K; Drinkenburg WH; Ahnaou A; Te Riele P; Langlois X; Hrupka B; De Haes P; Hendrickx H; Aerts N; Hens K; Wellens A; Vermeire J; Megens AA
    ACS Chem Neurosci; 2014 Oct; 5(10):1005-19. PubMed ID: 25203719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine A
    Jacobson KA; Gao ZG; Matricon P; Eddy MT; Carlsson J
    Br J Pharmacol; 2022 Jul; 179(14):3496-3511. PubMed ID: 32424811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation.
    Quarta D; Borycz J; Solinas M; Patkar K; Hockemeyer J; Ciruela F; Lluis C; Franco R; Woods AS; Goldberg SR; Ferré S
    J Neurochem; 2004 Nov; 91(4):873-80. PubMed ID: 15525341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual A
    Sanni O; Terre'Blanche G
    BMC Endocr Disord; 2023 May; 23(1):97. PubMed ID: 37143025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.